Greetings to my fellow investing adventurers,
Here are my results through March 31, 2018.
YTD through March: held steady at +20%
S&P: -1%
.IXIC: 2% (NASDAQ)
IWM: 0% (Russell 2000)
Top holdings - % growth
CRSP (CRISPR Therapeutics) + 94.7%
ABMD (Abiomed) +55.3%
NFLX (Netflix) +53.9%
SQ (Square) +41.9%
NTNX (Nutanix) +39.2%
AYX (Alteryx) +35.1%
PAYC (Paycom) +33.7%
INST (Instructure) +27.3%
SHOP (Shopify) +23.4%
HUBS (Hubspot) +22.5%
Top holdings - % of total portfolio
NFLX (Netflix) 24.9%
AAPL (Apple) 5.5%
GOOG/L (Alphabet) 4%
CASH ($$) 4%
BRK-B (Berkshire Hathaway) 3.7%
AYX (Alteryx) 3.2%
NTNX (Nutanix) 3%
NVDA (Nividia) 2.9%
ABMD (Abiomed) 2.7%
MFA (MFA Financial) 2.6%
MELI (Mercado Libre) 2.2%
TOP 10 HOLDINGS = 58.7% of portfolio
March activity:
Sold MKTX (Marketaxess), NTES (Netease), UBNT (Ubiquiti Networks), and TCX (Tucows).
Purchased EDIT (Editas Medicine), TEAM (Atlassian Corporation), and OKTA.
April has started out bumpy; it will be interesting to see how this month shapes up.
~Tracy